Other
Serious rashes requiring hospitalization including Stevens-Johnson syndrome and discontinuation of treatment have occurred in 0. Almost all life-threatening rashes have occurred within 2- 8 weeks of lamotrigine therapy, but they have also occurred after prolonged treatment; duration cannot be relied on as a means to predict the potential risk heralded by the first appearance of a rash. |
Serious rashes requiring hospitalization including Stevens-Johnson syndrome and discontinuation of treatment have occurred in 0. Almost all life-threatening rashes have occurred within 2- 8 weeks of lamotrigine therapy, but they have also occurred after prolonged treatment; duration cannot be relied on as a means to predict the potential risk heralded by the first appearance of a rash. |
Lamotrigine belongs to a class of medications known as antiepileptics. |
The items in your order may be shipped from any of the above jurisdictions. |
Lamotrigine may cause a severe or life-threatening skin rash, especially in children and in people who take a very high starting dose, or those who also take valproic acid Depakene or divalproex Depakote. |
Lamotrigine is an antiepileptic drug belonging in the phenyltriazine class. It is used in the treatment of both epilepsy and as a mood stabilizer in bipolar disorder. |
GlaxoSmithKline Ireland Ltd. Product subject to medical prescription which may be renewed B. |
Error: This is required. Error: Not a valid value. |
Common side effects include sleepiness, headache, vomiting, trouble with coordination, and rash. |
If you have not discussed this with your doctor or are not sure why you are taking this medication, speak to your doctor. Nonmedicinal ingredients: aluminum magnesium silicate, blackcurrant flavour, calcium carbonate, hydroxypropylcellulose, magnesium stearate, povidone, saccharin sodium, and sodium starch glycolate. |









